Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 2, 2008 - Issue 2
Submit an article Journal homepage
37
Views
5
CrossRef citations to date
0
Altmetric
Review

Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance

Jennifer S Carew1 The CTRC Institute for Drug Development, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
,
Steffan T Nawrocki1 The CTRC Institute for Drug Development, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
,
Francis J Giles1 The CTRC Institute for Drug Development, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
&
John L Cleveland2 The Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL, USACorrespondence[email protected]
Pages 201-204 | Published online: 06 Jun 2008

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Devalingam Mahalingam, Monica Mita, John Sarantopoulos, Leslie Wood, Ravi K Amaravadi, Lisa E Davis, Alain C Mita, Tyler J Curiel, Claudia M Espitia, Steffan T Nawrocki, Francis J Giles & Jennifer S Carew. (2014) Combined autophagy and HDAC inhibition. Autophagy 10:8, pages 1403-1414.
Read now
Jennifer S Carew, Kevin R Kelly & Steffan T Nawrocki. (2012) Autophagy as a target for cancer therapy: new developments. Cancer Management and Research 4, pages 357-365.
Read now
Ji-An Pan, Erica Ullman, Zhixun Dou & Wei-Xing Zong. (2011) Inhibition of Protein Degradation Induces Apoptosis through a Microtubule-Associated Protein 1 Light Chain 3-Mediated Activation of Caspase-8 at Intracellular Membranes. Molecular and Cellular Biology 31:15, pages 3158-3170.
Read now
Aine Carol Burke, Ronan T Swords, Kevin Kelly & Francis J Giles. (2011) Current status of agents active against the T315I chronic myeloid leukemia phenotype. Expert Opinion on Emerging Drugs 16:1, pages 85-103.
Read now

Articles from other publishers (1)

Wei Zhou, Libo Liu, Yixue Xue, Jian Zheng, Xiaobai Liu, Jun Ma, Zhen Li & Yunhui Liu. (2017) Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway. Frontiers in Molecular Neuroscience 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.